Clinical Trial Update: Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating neoadjuvant modified FOLFIRINOX with perioperative oral hydroxychloroquine in patients with resectable pancreatic adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Hydroxychloroquine (hydroxychloroquine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: West Virginia University | Conditions: Adenocarcinoma of the Pancreas | Phase 1, Phase 2 | Status: RECRUITING